Clinical Trial Update: Interleukin-23 Monoclonal Antibody for Inflammatory Bowel Disease: Efficacy and Safety [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating efficacy and safety of an interleukin-23 monoclonal antibody for inflammatory bowel disease is currently recruiting. The study includes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Interleukin-23 monoclonal antibody

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Crohn's Disease and Ulcerative Colitis | Phase 4 | Status: RECRUITING